Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects

Phase 4 Completed 224 enrolled GlaxoSmithKline

RandomizedCrossoverOpen-labelTreatment

Summary

The study will evaluate the pharmaco-economic consequences of the use of a remifentanil based regimen compared with a conventional sedative based regimen in terms of duration of mechanical ventilation, length of stay in ICU, difference in extubation time and use of concomitant sedative agents.

Timeline

Start: 2004-09
Primary completion: —
Completion: —

Publications

Al MJ, Hakkaart L, Tan SS, Bakker J. Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands. Crit Care. 2010;14(6):R195. doi: 10.1186/cc9313. Epub 2010 Nov 1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fentanyl	Other / unclassified	—	—
Subject	Lorazepam	Small molecule	—	—
Subject	Midazolam	Small molecule	—	—
Subject	Morphine	Other / unclassified	—	—
Subject	Propofol	Small molecule	—	—
Subject	Remifentanil	Small molecule	—	—

Indications

No indication recorded.